UK Chooses mRNA Boosters For COVID-19 Vaccination Campaign
Executive Summary
In making its recommendations for the autumn vaccination program against COVID-19, the UK’s JCVI says Novavax’s Nuvaxovid could be used in exceptional circumstances, but there is no room for AstraZeneca’s Vaxzevria.